Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Influence of Cholesterol on the Orientation of the Farnesylated GTP-bound KRas-4B Binding with Anionic Model Membranes

Version 1 : Received: 10 October 2020 / Approved: 12 October 2020 / Online: 12 October 2020 (12:31:28 CEST)

How to cite: Lu, H.; Martí, J. Influence of Cholesterol on the Orientation of the Farnesylated GTP-bound KRas-4B Binding with Anionic Model Membranes. Preprints 2020, 2020100239 (doi: 10.20944/preprints202010.0239.v1). Lu, H.; Martí, J. Influence of Cholesterol on the Orientation of the Farnesylated GTP-bound KRas-4B Binding with Anionic Model Membranes. Preprints 2020, 2020100239 (doi: 10.20944/preprints202010.0239.v1).

Abstract

The Ras family of proteins is tethered to the inner leaflet of the cell membranes which play an essential role in signal transduction pathways that promote cellular proliferation, survival, growth, and differentiation. KRas-4B, the most mutated Ras isoform in different cancers, has been under extensive study for more than two decades. Here we have focused our interest on the influence of cholesterol on the orientations that KRas-4B adopts with respect to the plane of the anionic model membranes. How cholesterol in the bilayer might modulate preferences for specific orientation states is far from clear. Herein, after analyzing data from in total 4000 ns-long MD simulations for four KRas-4B systems, properties such as the area per lipid and thickness of the membrane as well as selected radial distribution functions, penetration of different moieties of KRas-4B, and internal conformational fluctuations of flexible moieties in KRas-4B have been calculated. It has been shown that high cholesterol content in the PM favors OS1, exposing the effector-binding loop for signal transduction in the cell from the atomic level. We confirm that high cholesterol in the PM helps KRas-4B mutant stay in its constitutively active state, which suggests that high cholesterol intake can increase mortality and may promote cancer progression for cancer patients. We propose that during the treatment of KRas-4B-related cancers, reducing the cholesterol level in the PM and sustaining cancer progression by controlling the plasma cholesterol intake might be taken into account in anti-cancer therapies.

Subject Areas

KRas-4B; mutation; post-translational modification; HVR; anionic plasma membrane; signaling; cholesterol

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.